GlassScriptPhysician profile
Siyu Li
NPI 1316588148
$2,766.63
in general payments reported to CMS, 2019-2025
24 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,236 · 2022: $429 · 2023: $701 · 2024: $262 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $478.55 | 2021-2024 | Mounjaro, Trulicity, Zepbound |
| Astrazeneca Pharmaceuticals LP | $373.68 | 2021-2024 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $295.05 | 2021-2024 | |
| Amarin Pharma, INC. | $288.69 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $271.92 | 2021-2022 | |
| Glaxosmithkline, LLC. | $245.04 | 2021-2023 | Trelegy Ellipta |
| Amgen INC. | $121.58 | 2021-2024 | Prolia, Evenity |
| Corcept Therapeutics | $121.20 | 2025 | Korlym |
| Pfizer INC. | $82.49 | 2021-2023 | |
| Bausch Health US, LLC | $72.59 | 2021-2022 | |
| Eisai INC. | $60.89 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $53.64 | 2022-2023 | Quviviq |
| Merck Sharp & Dohme LLC | $40.71 | 2021-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Hikma Pharmaceuticals USA | $38.09 | 2021-2023 | Ryaltris |
| Novo Nordisk INC | $37.17 | 2022-2023 | Wegovy |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $36.58 | 2022 | |
| Inari Medical, INC. | $27.08 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zimmer Biomet Holdings, INC. | $23.55 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Eyevance Pharmaceuticals LLC | $22.04 | 2021 | |
| Currax Pharmaceuticals LLC | $17.36 | 2025 | Contrave |
| Exact Sciences Corporation | $17.32 | 2024 | Cologuard Collection Kit |
| Genentech USA, INC. | $14.66 | 2021 | |
| Qiagen, LLC | $13.77 | 2021 | |
| Antares Pharma, INC. | $12.98 | 2023 | Nocdurna, Tlando, Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siyu Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.